HomeCompareCGUI vs JNJ

CGUI vs JNJ: Dividend Comparison 2026

CGUI yields 4.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $4.5K in total portfolio value· pulled ahead in Year 9
10 years
CGUI
CGUI
● Live price
4.00%
Share price
$25.28
Annual div
$1.01
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$516.95
Full CGUI calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CGUI vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGUIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGUI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGUI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGUI
Annual income on $10K today (after 15% tax)
$339.92/yr
After 10yr DRIP, annual income (after tax)
$439.41/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,597.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGUI + JNJ for your $10,000?

CGUI: 50%JNJ: 50%
100% JNJ50/50100% CGUI
Portfolio after 10yr
$28.2K
Annual income
$2,633.42/yr
Blended yield
9.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CGUI
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGUI buys
0
JNJ buys
0
No recent congressional trades found for CGUI or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGUIJNJ
Forward yield4.00%2.14%
Annual dividend / share$1.01$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$25.9K$30.5K
Annual income after 10y$516.95$4,749.88
Total dividends collected$4.6K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGUI vs JNJ ($10,000, DRIP)

YearCGUI PortfolioCGUI Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,100$399.90$10,594$274.49+$506.00CGUI
2$12,292$414.85$11,294$360.69+$998.00CGUI
3$13,581$429.34$12,133$476.91+$1.4KCGUI
4$14,976$443.35$13,156$635.42+$1.8KCGUI
5$16,481$456.88$14,432$854.61+$2.0KCGUI
6$18,104$469.90$16,056$1,162.76+$2.0KCGUI
7$19,854$482.43$18,175$1,604.53+$1.7KCGUI
8$21,738$494.44$21,009$2,252.68+$729.00CGUI
9← crossover$23,766$505.95$24,911$3,229.73$1.1KJNJ
10$25,946$516.95$30,458$4,749.88$4.5KJNJ

CGUI vs JNJ: Complete Analysis 2026

CGUIStock

To provide current income consistent with an ultra-short duration profile, focused on preservation of capital.Distinguishing Characteristics The fund invests primarily in U.S. dollar denominated, investment-grade, short-term debt, including short-term money market instruments such as commercial paper and certificates of deposit, U.S. government bonds, corporate securities and asset-backed securities. The fund will normally invest more than 25% of its assets in securities issued by companies in the financials group of industries. The fund may invest substantially in debt securities that are tied economically to countries outside the United States, including securities issued by foreign corporations or foreign governments and their agencies and instrumentalities. The fund may also invest in futures contracts and swaps, which are types of derivatives. A derivative is a financial contract, the value of which is based on the value of an underlying financial asset (such as a stock, bond or currency), a reference rate or a market index.The fund will invest at least 80% of its assets in bonds and other debt securities that accrue income, which may be represented by derivatives. The fund consists primarily of investment-grade debt with a minimum short-term rating of P-2, A-2, F2, or a minimum long-term rating of BBB- or Baa3, in each case given by the Nationally Recognized Statistical Rating Organizations designated by the fund’s investment adviser or unrated but determined to be of equivalent quality by the fund’s investment adviser. The fund may invest up to 5% in debt securities rated BB+ or Ba1 or below, but with a minimum rating of BB- (or Ba3). The fund normally seeks to maintain an average portfolio duration of one year or less, and a dollar-weighted average maturity of two years or less. The fund will normally invest more than 25% of its assets in securities issued by companies in the financials group of industries.

Full CGUI Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CGUI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGUI vs SCHDCGUI vs JEPICGUI vs OCGUI vs KOCGUI vs MAINCGUI vs ABBVCGUI vs MRKCGUI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.